$4.36 Billion is the total value of ARMISTICE CAPITAL, LLC's 111 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CYTHW | Exit | CYCLO THERAPEUTICS INC*w exp 11/14/202 | $0 | – | -50,000 | -100.0% | -0.01% | – |
| MOTS | Exit | MOTUS GI HLDGS INC | $0 | – | -347,221 | -100.0% | -0.01% | – |
| CYTH | Exit | CYCLO THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.02% | – |
| TMDI | Exit | TITAN MED INC | $0 | – | -278,787 | -100.0% | -0.02% | – |
| VXRT | Exit | VAXART INC | $0 | – | -145,523 | -100.0% | -0.03% | – |
| GOVXW | Exit | GEOVAX LABS INC*w exp 09/29/202 | $0 | – | -391,700 | -100.0% | -0.03% | – |
| SRGA | Exit | SURGALIGN HOLDINGS INC | $0 | – | -436,000 | -100.0% | -0.03% | – |
| KBNTW | Exit | KUBIENT INC*w exp 07/09/202 | $0 | – | -275,000 | -100.0% | -0.04% | – |
| CBLI | Exit | CLEVELAND BIOLABS INC | $0 | – | -320,053 | -100.0% | -0.04% | – |
| PTE | Exit | POLARITYTE INC | $0 | – | -1,689,220 | -100.0% | -0.04% | – |
| LMNL | Exit | LIMINAL BIOSCIENCES INC | $0 | – | -565,242 | -100.0% | -0.08% | – |
| BXRX | Exit | BAUDAX BIO INC | $0 | – | -3,503,351 | -100.0% | -0.12% | – |
| VFC | Exit | V F CORP | $0 | – | -49,781 | -100.0% | -0.14% | – |
| CRI | Exit | CARTERS INC | $0 | – | -52,404 | -100.0% | -0.17% | – |
| SELB | Exit | SELECTA BIOSCIENCES INC | $0 | – | -1,636,000 | -100.0% | -0.17% | – |
| CRWD | Exit | CROWDSTRIKE HLDGS INCcl a | $0 | – | -25,000 | -100.0% | -0.18% | – |
| SMAR | Exit | SMARTSHEET INC | $0 | – | -82,000 | -100.0% | -0.19% | – |
| NEPT | Exit | NEPTUNE WELLNESS SOLUTIONS I | $0 | – | -4,166,666 | -100.0% | -0.22% | – |
| PRTS | Exit | CARPARTS COM INC | $0 | – | -550,000 | -100.0% | -0.23% | – |
| AVNS | Exit | AVANOS MED INC | $0 | – | -156,000 | -100.0% | -0.24% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -2,256,000 | -100.0% | -0.37% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -172,000 | -100.0% | -0.39% | – |
| EPC | Exit | EDGEWELL PERS CARE CO | $0 | – | -336,000 | -100.0% | -0.40% | – |
| PG | Exit | PROCTER AND GAMBLE CO | $0 | – | -87,000 | -100.0% | -0.41% | – |
| KHC | Exit | KRAFT HEINZ CO | $0 | – | -400,000 | -100.0% | -0.47% | – |
| VTRS | Exit | VIATRIS INC | $0 | – | -936,000 | -100.0% | -0.60% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -500,000 | -100.0% | -0.61% | – |
| DKS | Exit | DICKS SPORTING GOODS INC | $0 | – | -332,389 | -100.0% | -0.64% | – |
| BCOR | Exit | BLUCORA INC | $0 | – | -1,328,000 | -100.0% | -0.72% | – |
| BURL | Exit | BURLINGTON STORES INC | $0 | – | -97,443 | -100.0% | -0.87% | – |
| ROST | Exit | ROSS STORES INC | $0 | – | -212,284 | -100.0% | -0.89% | – |
| TGT | Exit | TARGET ORD | $0 | – | -178,687 | -100.0% | -1.07% | – |
| AZO | Exit | AUTOZONE INC | $0 | – | -27,589 | -100.0% | -1.11% | – |
| FTDR | Exit | FRONTDOOR INC | $0 | – | -656,000 | -100.0% | -1.12% | – |
| ULTA | Exit | ULTA BEAUTY INC | $0 | – | -138,304 | -100.0% | -1.35% | – |
| ORLY | Exit | OREILLY AUTOMOTIVE INC | $0 | – | -90,583 | -100.0% | -1.39% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.